360 related articles for article (PubMed ID: 16647380)
1. Safety of simple cystectomy in patients with unilateral mucinous borderline tumors.
Salomon LJ; Lhommé C; Pautier P; Duvillard P; Morice P
Fertil Steril; 2006 May; 85(5):1510.e1-4. PubMed ID: 16647380
[TBL] [Abstract][Full Text] [Related]
2. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
[TBL] [Abstract][Full Text] [Related]
3. Identical twins with ovarian endometriosis and mucinous borderline tumor: an unusual association.
Ko ML; Pan HS
Fertil Steril; 2008 Oct; 90(4):1200.e7-9. PubMed ID: 18258232
[TBL] [Abstract][Full Text] [Related]
4. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study.
Fauvet R; Poncelet C; Boccara J; Descamps P; Fondrinier E; Daraï E
Fertil Steril; 2005 Feb; 83(2):284-90; quiz 525-6. PubMed ID: 15705364
[TBL] [Abstract][Full Text] [Related]
5. Ovarian mucinous borderline tumors of intestinal type without intraepithelial carcinoma: are they still tumors of low malignant potential?
Nomura K; Aizawa S; Hano H
Pathol Int; 2004 Jun; 54(6):420-4. PubMed ID: 15144401
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors.
Yinon Y; Beiner ME; Gotlieb WH; Korach Y; Perri T; Ben-Baruch G
Fertil Steril; 2007 Aug; 88(2):479-84. PubMed ID: 17408624
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopic fertility-sparing staging in unexpected early stage ovarian malignancies.
Muzii L; Palaia I; Sansone M; Calcagno M; Plotti F; Angioli R; Panici PB
Fertil Steril; 2009 Jun; 91(6):2632-7. PubMed ID: 18555237
[TBL] [Abstract][Full Text] [Related]
8. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
Cao DY; Shen K; Tao T; Yang JX; Xiang Y; Huang HF; Wu M; Pan LY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
[TBL] [Abstract][Full Text] [Related]
10. Conservative treatment of borderline ovarian tumors.
Tazelaar HD; Bostwick DG; Ballon SC; Hendrickson MR; Kempson RL
Obstet Gynecol; 1985 Sep; 66(3):417-22. PubMed ID: 4022501
[TBL] [Abstract][Full Text] [Related]
11. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
12. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
[TBL] [Abstract][Full Text] [Related]
13. [Epithelial ovarian tumors in adolescence: a study of clinical features and treatment].
Li M; Pan LY; Huang HF; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):598-601. PubMed ID: 15498186
[TBL] [Abstract][Full Text] [Related]
14. Feasibility, safety, and efficacy of conservative laparoscopic treatment of borderline ovarian tumors.
Tinelli R; Malzoni M; Cosentino F; Perone C; Tinelli A; Malvasi A; Cicinelli E
Fertil Steril; 2009 Aug; 92(2):736-41. PubMed ID: 18793773
[TBL] [Abstract][Full Text] [Related]
15. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
[TBL] [Abstract][Full Text] [Related]
16. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
[TBL] [Abstract][Full Text] [Related]
17. Port-site implantation after laparoscopic treatment of borderline ovarian tumors.
Morice P; Camatte S; Larregain-Fournier D; Thoury A; Duvillard P; Castaigne D
Obstet Gynecol; 2004 Nov; 104(5 Pt 2):1167-70. PubMed ID: 15516439
[TBL] [Abstract][Full Text] [Related]
18. Behaviour of ovarian tumors of low malignant potential treated with conservative surgery.
De Iaco P; Ferrero A; Rosati F; Melpignano M; Biglia N; Rolla M; De Aloysio D; Sismondi P
Eur J Surg Oncol; 2009 Jun; 35(6):643-8. PubMed ID: 19013745
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and prognosis of mucinous tumors of the ovary.
Kikkawa F; Nawa A; Kajiyama H; Shibata K; Ino K; Nomura S
Gynecol Oncol; 2006 Oct; 103(1):171-5. PubMed ID: 16546243
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
Jordan SJ; Green AC; Whiteman DC; Webb PM;
Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
